Retinopathy and Systemic Disease Morbidity in Severe COVID-19.
Shantha JG, Auld SC, Anthony C, Ward L, Adelman MW, Maier CL, Price KW, Jacob JT, Fashina T, Randleman C, Xu LT, Barnett J, Sadan O, Kandiah PA, Varkey JB, Kraft CS, Rouphael N, Linderman S, Ahmed R, Drews-Botsch C, Waggoner JJ, Weinmann M, Murphy DJ, Yeh S; Emory COVID-19 Quality and Clinical Research Collaborative.
Shantha JG, et al.
Ocul Immunol Inflamm. 2021 May 19;29(4):743-750. doi: 10.1080/09273948.2021.1952278. Epub 2021 Aug 31.
Ocul Immunol Inflamm. 2021.
PMID: 34464544
Free PMC article.
PURPOSE: To assess the prevalence of retinopathy and its association with systemic morbidity and laboratory indices of coagulation and inflammatory dysfunction in severe COVID-19. DESIGN: Retrospective, observational cohort study. METHODS: Adult patients hospitalize …
PURPOSE: To assess the prevalence of retinopathy and its association with systemic morbidity and laboratory indices of coagulation and infla …